Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Diagnosis of Alzheimer's disease (AD) is very important, and MRI is an effective imaging...
OBJECTIVES: To explore whether severity of cognitive impairment and agitation of older people with d...
Brain-wide and genome-wide association (BW-GWA) study is presented in this paper to identify the ass...
BACKGROUND: The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) developed a neuro...
Alzheimer's disease (AD) is a progressive brain disease. The goal of this study is to provide a new ...
Early diagnosis is critical for individuals with Alzheimer's disease (AD) in clinical practice becau...
Discriminating Alzheimer's disease (AD) from its prodromal form, mild cognitive impairment (MCI), is...
Dementia with Lewy bodies (DLB) and Alzheimer's disease (AD) require differential management despite...
To develop a new method for measuring Alzheimer's disease (AD)-specific similarity of cortical atrop...
BACKGROUND: There is a spectrum of the progression from healthy control (HC) to mild cognitive impai...
Alzheimer's disease (AD) is one of the most common neurodegenerative diseases with a commonly seen p...
BACKGROUND: The International Challenge for Automated Prediction of MCI from MRI data offered indepe...
This article provides data for five different neuropsychiatric disorders-Attention Deficit Hyperacti...
The depression, anxiety and physiosomatic symptoms (DAPS) of schizophrenia are associated with negat...
BACKGROUND: The novel molecule endocan, which is released by endothelium and is regulated by proangi...
Discriminative methods commonly produce models with relatively good generalization abilities. Howeve...
Online learning has been successfully applied in various machine learning problems. Conventional ana...
OBJECTIVES: The robotic seal, PARO, has been used as an alternative to animal-assisted therapies wit...
Alzheimer's disease (AD) is a major neurodegenerative disease and the most common cause of dementia....
BACKGROUND: Alzheimer's disease (AD) is an important, progressive neurodegenerative disease, with a ...
OBJECTIVES: To examine the within-trial costs and cost-effectiveness of using PARO, compared with a ...